guidance cut – Talk Bio

Actionable Insights Powered by AI

Novo Nordisk Appoints New CEO and Reduces 2025 Sales Guidance

Novo Nordisk; CEO change; Maziar Mike Doustdar; 2025 sales guidance cut; growth outlook; leadership transition; obesity drug competition